372 related articles for article (PubMed ID: 33563578)
1. Leveraging Single-Cell Approaches in Cancer Precision Medicine.
Nath A; Bild AH
Trends Cancer; 2021 Apr; 7(4):359-372. PubMed ID: 33563578
[TBL] [Abstract][Full Text] [Related]
2. Intratumor heterogeneity: evolution through space and time.
Swanton C
Cancer Res; 2012 Oct; 72(19):4875-82. PubMed ID: 23002210
[TBL] [Abstract][Full Text] [Related]
3. Advancing Cancer Research and Medicine with Single-Cell Genomics.
Lim B; Lin Y; Navin N
Cancer Cell; 2020 Apr; 37(4):456-470. PubMed ID: 32289270
[TBL] [Abstract][Full Text] [Related]
4. SpliceHetero: An information theoretic approach for measuring spliceomic intratumor heterogeneity from bulk tumor RNA-seq.
Kim M; Lee S; Lim S; Kim S
PLoS One; 2019; 14(10):e0223520. PubMed ID: 31644551
[TBL] [Abstract][Full Text] [Related]
5. Computational Approaches for the Investigation of Intra-tumor Heterogeneity and Clonal Evolution from Bulk Sequencing Data in Precision Oncology Applications.
Laganà A
Adv Exp Med Biol; 2022; 1361():101-118. PubMed ID: 35230685
[TBL] [Abstract][Full Text] [Related]
6. Single-Cell Sequencing Technologies in Precision Oncology.
Melnekoff DT; Laganà A
Adv Exp Med Biol; 2022; 1361():269-282. PubMed ID: 35230694
[TBL] [Abstract][Full Text] [Related]
7. Role of the Immune Component of Tumor Microenvironment in the Efficiency of Cancer Treatment: Perspectives for the Personalized Therapy.
Stakheyeva M; Riabov V; Mitrofanova I; Litviakov N; Choynzonov E; Cherdyntseva N; Kzhyshkowska J
Curr Pharm Des; 2017; 23(32):4807-4826. PubMed ID: 28714406
[TBL] [Abstract][Full Text] [Related]
8. Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.
Biswas A; De S
Am J Physiol Cell Physiol; 2021 May; 320(5):C750-C760. PubMed ID: 33657326
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine.
Kanzaki R; Pietras K
Cancer Sci; 2020 Aug; 111(8):2708-2717. PubMed ID: 32573845
[TBL] [Abstract][Full Text] [Related]
10. Tracing Clonal Dynamics Reveals that Two- and Three-dimensional Patient-derived Cell Models Capture Tumor Heterogeneity of Clear Cell Renal Cell Carcinoma.
Bolck HA; Corrò C; Kahraman A; von Teichman A; Toussaint NC; Kuipers J; Chiovaro F; Koelzer VH; Pauli C; Moritz W; Bode PK; Rechsteiner M; Beerenwinkel N; Schraml P; Moch H
Eur Urol Focus; 2021 Jan; 7(1):152-162. PubMed ID: 31266731
[TBL] [Abstract][Full Text] [Related]
11. A Portrait of Intratumoral Genomic and Transcriptomic Heterogeneity at Single-Cell Level in Colorectal Cancer.
Angius A; Scanu AM; Arru C; Muroni MR; Carru C; Porcu A; Cossu-Rocca P; De Miglio MR
Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833475
[TBL] [Abstract][Full Text] [Related]
12. Understanding tumor ecosystems by single-cell sequencing: promises and limitations.
Ren X; Kang B; Zhang Z
Genome Biol; 2018 Dec; 19(1):211. PubMed ID: 30509292
[TBL] [Abstract][Full Text] [Related]
13. Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine.
Hiley C; de Bruin EC; McGranahan N; Swanton C
Genome Biol; 2014 Aug; 15(8):453. PubMed ID: 25222836
[TBL] [Abstract][Full Text] [Related]
14. New insights from the widening homogeneity perspective to target intratumor heterogeneity.
Tong M; Deng Z; Zhang X; He B; Yang M; Cheng W; Liu Q
Cancer Commun (Lond); 2018 May; 38(1):17. PubMed ID: 29764517
[TBL] [Abstract][Full Text] [Related]
15. A Practical Approach to Tumor Heterogeneity in Clinical Research and Diagnostics.
Stanta G; Bonin S
Pathobiology; 2018; 85(1-2):7-17. PubMed ID: 28750401
[TBL] [Abstract][Full Text] [Related]
16. Intratumor heterogeneity: A new perspective on colorectal cancer research.
Zheng Z; Yu T; Zhao X; Gao X; Zhao Y; Liu G
Cancer Med; 2020 Oct; 9(20):7637-7645. PubMed ID: 32853464
[TBL] [Abstract][Full Text] [Related]
17. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.
McGranahan N; Swanton C
Cell; 2017 Feb; 168(4):613-628. PubMed ID: 28187284
[TBL] [Abstract][Full Text] [Related]
18. Intratumor Heterogeneity: Novel Approaches for Resolving Genomic Architecture and Clonal Evolution.
Gupta RG; Somer RA
Mol Cancer Res; 2017 Sep; 15(9):1127-1137. PubMed ID: 28596419
[TBL] [Abstract][Full Text] [Related]
19. Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.
Morris LG; Riaz N; Desrichard A; Şenbabaoğlu Y; Hakimi AA; Makarov V; Reis-Filho JS; Chan TA
Oncotarget; 2016 Mar; 7(9):10051-63. PubMed ID: 26840267
[TBL] [Abstract][Full Text] [Related]
20. Microfluidic design in single-cell sequencing and application to cancer precision medicine.
Han X; Xu X; Yang C; Liu G
Cell Rep Methods; 2023 Sep; 3(9):100591. PubMed ID: 37725985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
